TrialNeuro-oncology2025

Phase 3 randomized trial of high-dose methotrexate for young children with high-risk embryonal brain tumors: A report from the Children's Oncology Group.

Claire Mazewski et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.